Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.

ABSTRACT:

SUBMITTER: Zu Y 

PROVIDER: S-EPMC9834295 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature